USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
EU COVID-19 Vaccine and Therapeutics Insights, Trends, and Growth Opportunities
EU COVID-19 Vaccine and Therapeutics Insights, Trends, and Growth Opportunities
Future Growth Potential Driven by Capabilities and Expertise in Vaccine Manufacturing
26-Nov-2021
Europe
$2,450.00
Special Price $1,837.50 save 25 %
Description
With this research service, Frost & Sullivan’s Healthcare and Life Sciences team provides critical insights into the European Union and UK COVID-19 vaccine and therapeutics market. The report analyzes COVID-19 vaccines and therapeutics in development and delves into supply chain considerations and requirements to manage distribution. Importantly, the study identifies actionable growth opportunities for industry participants. Like the United States, the European Union received criticism for vaccine nationalism, but it is taking steps to encourage global vaccine access. It has launched the Team Europe initiative for improving manufacturing and access to vaccines, medicines, and health technologies in Africa.
Initiatives such as the EU Digital Vaccination Passport and UK NHS COVID Pass app will help Europe in safe reopening and overcoming COVID-19 variants of concern to a certain extent. Although vaccinations are progressing at a fast pace, factors that will determine campaigns’ future course include political and religious situations, vaccine availability and access, and vaccine hesitancy specifically in younger population groups. The low vaccination rate in Central and Eastern Europe (CEE) is fueling another COVID-19 surge (especially because of the Delta variant) and causing a healthcare crisis in Bulgaria, Romania and Latvia.
Topics covered include:
• Analyses of COVID-19 vaccines and therapeutics
• Strategies of vaccine manufacturers to scale up their global manufacturing network
• COVID-19 vaccination rollouts
• The role of digital technology in the COVID-19 battle
• The Growth Opportunity Universe
Author: Surbhi Gupta
Table of Contents
Why is it Increasingly Difficult to Grow?
The Strategic Imperative 8™
The Impact of the Top Three Strategic Imperatives for the EU COVID-19 Vaccine and Therapeutics Market
Growth Opportunities Fuel the Growth Pipeline Engine™
Highlights
Regional Impact of COVID-19 Vaccinations
Scope of Analysis
Growth Drivers for Recovery from the COVID-19 Pandemic
Growth Restraints for Recovery from the COVID-19 Pandemic
COVID-19 Vaccine Pipeline Analysis
Overview of Key Authorized COVID-19 Vaccines Globally
Selected Vaccine Candidates in Phase III
Key Small Molecules in Late Stage of Development (Antivirals and Immunomodulators)
Key mAbs in Late Stage of Development
EU COVID-19 Therapeutics Snapshot
Pfizer/BioNTech Vaccines
Moderna
J&J
Oxford/AZ
Novavax
Capacity Secured
Distribution of COVID-19 Vaccine Doses by Manufacturer
Percentage of Adults Fully Vaccinated Against COVID-19
COVID-19 Vaccination Doses Administered in Selected Countries
Germany—Approaching the 70% First-dose Milestone
France—More than 70% of the Population Fully Vaccinated
Italy—Reached the 70% First-dose Milestone
UK—First European Country to Reach the 70% First-dose Milestone
Behind the Successful UK Rollout
DHL Express Hub and Gateway Model
Digital Technology Platforms Enabling Data Management, Vaccination, and Rebounding from COVID-19
EU COVID-19 Certificate/Health Pass
IBM Digital Health Pass
Growth Opportunity 1—Additional and Booster Doses for Waning Immunity and Emerging Virus Variants
Growth Opportunity 1—Additional and (continued)
Growth Opportunity 2—Strengthening Domestic Manufacturing for Leading Global Supply of COVID-19 Vaccine
Growth Opportunity 2—Strengthening Domestic Manufacturing for Leading Global Supply of COVID-19 Vaccine (continued)
Growth Opportunity 3—Global Standard Solution for Recognising and Verifying Individual Countries’ COVID-19 Health Pass
Growth Opportunity 3—Global Standard Solution for Recognising and Verifying Individual Countries’ COVID-19 Health Pass (continued)
List of Exhibits
List of Exhibits (continued)
Legal Disclaimer
Popular Topics
| No Index | No |
|---|---|
| Podcast | No |
| Author | Surbhi Gupta |
| Industries | Healthcare |
| WIP Number | PC55-01-00-00-00 |
| Is Prebook | No |
| GPS Codes | 9600-B1,9571-B1,9611-B1 |